Reaction
Corneal Disorder reporting signals
As of the last recalculation, Corneal Disorder appears in 2,143 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is PREDNISOLONE ACETATE (PRR 62.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Prednisolone Acetate | 65 | 62.9 | 63.3 |
| Brinzolamide | 31 | 35.2 | 35.3 |
| Moxifloxacin Hydrochloride | 51 | 25.0 | 25.1 |
| Latanoprost | 99 | 20.0 | 20.0 |
| Brimonidine Tartrate | 36 | 19.9 | 20.0 |
| Timolol Maleate | 20 | 19.8 | 19.8 |
| Carboxymethylcellulose Sodium | 18 | 18.8 | 18.8 |
| Moxifloxacin | 25 | 17.4 | 17.5 |
| Timolol | 20 | 16.2 | 16.2 |
| Travoprost | 14 | 15.8 | 15.8 |
| Lifitegrast | 26 | 15.6 | 15.7 |
| Ado-Trastuzumab Emtansine | 13 | 15.1 | 15.1 |
| Ranibizumab | 38 | 14.1 | 14.2 |
| Dorzolamide Hydrochloride And Timolol Maleate | 11 | 13.6 | 13.6 |
| Cenegermin-Bkbj | 15 | 12.1 | 12.1 |
| Aflibercept | 38 | 12.0 | 12.0 |
| Tobramycin Sulfate | 15 | 11.8 | 11.9 |
| Tobramycin Solution | 14 | 11.4 | 11.4 |
| Faricimab | 9 | 10.8 | 10.8 |
| Atropine Sulfate | 11 | 9.9 | 9.9 |
| Gefitinib | 8 | 8.6 | 8.6 |
| Ganciclovir | 9 | 8.6 | 8.6 |
| Bimatoprost | 24 | 8.2 | 8.2 |
| Ganciclovir Sodium | 8 | 7.4 | 7.4 |
| Erlotinib | 7 | 7.0 | 7.0 |
| Tobramycin | 17 | 6.9 | 6.9 |
| Erlotinib Hydrochloride | 8 | 6.2 | 6.2 |
| Voriconazole Injection | 12 | 5.4 | 5.4 |
| Amantadine | 8 | 5.0 | 5.0 |
| Pertuzumab | 13 | 4.7 | 4.7 |
| Memantine | 6 | 4.3 | 4.3 |
| Memantine Hydrochloride | 6 | 4.3 | 4.3 |
| Trastuzumab | 27 | 3.9 | 3.9 |
| Agalsidase Beta | 3 | 3.2 | 3.2 |
| Fam-Trastuzumab Deruxtecan-Nxki | 3 | 2.9 | 2.9 |